TVM_LOGO_RGB_NEU.jpg
TVM Capital Life Science to Participate in LSI USA ’24 Emerging Medtech Summit 2024
March 13, 2024 10:00 ET | TVM Life Science Management GmbH
TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
TVM_LOGO_RGB_NEU.jpg
TVM Capital Life Science Co-Leads $16 Million Series A Financing Round for Vektor Medical to Revolutionize Arrhythmia Care
February 06, 2024 04:07 ET | TVM Life Science Management GmbH
MUNICH, Germany and MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
TVM_LOGO_RGB_NEU.jpg
TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App
January 31, 2024 04:00 ET | TVM Life Science Management GmbH
MUNICH, Germany and MONTREAL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation,...
TVM logo_Jan 2023.jpg
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
July 20, 2023 08:00 ET | TVM Life Science Management GmbH
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to...
TVM logo_Jan 2023.jpg
TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
March 17, 2023 09:00 ET | TVM Life Science Management GmbH
MONTREAL and MUNICH, Germany, March 17, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
TVM logo_Jan 2023.jpg
TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
February 23, 2023 08:00 ET | TVM Life Science Management GmbH
MONTREAL, Canada and MUNICH, Germany, Feb. 23, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences...
TVM logo_Jan 2023.jpg
TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
February 08, 2023 08:00 ET | TVM Life Science Management GmbH
LAmAb Biologics to develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases LAmAb Biologics is the 9th early-stage or product focused...
TVM logo_Jan 2023.jpg
TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
February 01, 2023 08:00 ET | TVM Life Science Management GmbH
Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-001 delivered in...